TRAF3IP2 and neoplasm: By depleting the energy reserves of TNBC cells and reactivating these critical stress response pathways, TRAF3IP2 silencing exerts a potent anti-tumor effect, evidenced by the substantial reduction in ATP production and tumor viability.